The European Medicines Agency (EMA) has recommended the use of a Covid-19 vaccine made by US-based biotech firm Novavax for people aged 18 and older. Trial data suggests the vaccine is 90% effective. On Monday, the EMA backed the use of Nuvaxovid, a vaccine developed by Novavax, for adults, making it the fifth Covid shot […]
